ArticleThe Journal of membrane biology2021
Liposome Permeability to Essential Oil Components: A Focus on Cholesterol Content.
Article in The Journal of membrane biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 19 citations in OpenAlex.
- Pickering Emulsion Stabilized by Chitosan-ModifiedPharmaceuticals (Basel, Switzerland) · 2026Article
- Smart Microfluidics: A curated dataset of microfluidic liposome formulations with cross-laboratory validation for machine-learning applications.Data in brief · 2026Article
- Exploring the Antibacterial Potency of Cymbopogon Essential Oils: Liposome Encapsulation and Phytochemical Insights.Antibiotics (Basel, Switzerland) · 2025Article
- Preparation and Characterization of Universal Liquid Proliposomes Encapsulating Water-soluble Efficacious Substances.Current pharmaceutical biotechnology · 2025Article
- Microencapsulation to Harness the Antimicrobial Potential of Essential Oils and Their Applicability in Dairy Products: A Comprehensive Review of the Literature.Foods (Basel, Switzerland) · 2024Review
- Cyclodextrins permeabilize DPPC liposome membranes: a focus on cholesterol content, cyclodextrin type, and concentration.Beilstein journal of organic chemistry · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Encapsulation in liposomes has been an efficient strategy to improve the stability of sensitive bioactive compounds such as essential oils (EOs). However, the stability of liposomal formulations remains a key parameter controlling the delivery of encapsulated ingredients. Cholesterol (Chol) modulates the membrane properties conferring stability to the lipid bilayer. Thus, the Chol content in the liposome formulations encapsulating EO components should be carefully chosen. In this work, various liposome formulations differing by Chol content (DPPC:Chol 100:10; 100:25; 100:50; 100:75; 100:100) were exposed to a series of 22 EO components at DPPC/EO 100/25. The formulations were characterized for their final composition and their permeability to the hydrophilic fluorophore, sulforhodamine B (SRB), was monitored. Results showed that the Chol content experimentally determined for the various formulations (above 10% Chol) was below the theoretical weighed Chol. Among the tested components, 13 molecules displayed a significant permeabilizing effect on 10% Chol membranes. Most of these possess a hydroxyl group. The EO induced permeability was dependent on the Chol content which affects the membrane phase: their effect was reduced upon increasing Chol content keeping five EOs components effective at 40% Chol. The EO's effect was also linked to the hydrophobicity of the molecule. Hence, the DPPC:Chol ratio of the formulation is chosen considering the structure of the compound, its hydrophobicity and its effect on the permeability at different Chol content: a formulation comprising 40% Chol is suggested for highly hydrophobic molecules whereas a formulation with higher Chol content could be selected for less hydrophobic compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.